Sir Niall Ferguson Joins The Times
The Times announces Sir Niall Ferguson has joined as a contributing writer and will write 12 exclusive pieces per year. He offers his unique insights…
Thought Leader: Niall Ferguson
Gottlieb sets a new standard for FDA commissioner
By Scott Gottlieb (Original source Modern Healthcare)
“Dr. Scott Gottlieb has taken industry skeptics by surprise.
When the Trump administration tapped Gottlieb to lead the U.S. Food and Drug Administration last year, branded-drug manufacturers and their investors celebrated. Others were less exuberant.
Industry observers expected Gottlieb, who advised GlaxoSmithKline and was a board member for several other drug and device makers, to protect Big Pharma’s interests.
Yet, about a year later, the FDA commissioner has quieted many of his critics. An unprecedented level of transparency and public disclosure has garnered support from across the industry. Gottlieb has tried to curb drug prices by introducing more generics. The public health community praised his policies that look to lower salt content in food and nicotine in cigarettes, as well as crack down on opioid distributors and websites.”
Click here to see more
Relevant and recent posts
Dr. Sanjay Gupta: Is Ozempic Really A Miracle Drug?
New drugs like Wegovy, Ozempic and Mounjaro are billed as a revolutionary new approach for losing weight. But are these actually miracle drugs? Dr. Sanjay…
Thought Leader: Sanjay Gupta
Peter Zeihan: The Geopolitics of Climate Change
From Peter Zeihan: With a glacier as the backdrop for this video, I figured it only appropriate to discuss resource exploitation, Arctic shipping, and agriculture…
Thought Leader: Peter Zeihan
More with this speaker
Dr. Scott Gottlieb on Trump 2.0
Thought Leader: Scott Gottlieb
Dr. Scott Gottlieb to keynote MM+M Transform in April
Thought Leader: Scott Gottlieb